BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.62
+0.14 (1.65%)
At close: Mar 9, 2026, 4:00 PM EDT
8.65
+0.03 (0.34%)
After-hours: Mar 9, 2026, 4:34 PM EDT
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of $2.16 billion as of March 9, 2026. Its market cap has increased by 11.15% in one year.
Market Cap
2.16B
Enterprise Value
2.34B
1-Year Change
11.15%
Ranking
Category
Stock Price
$8.62
Market Cap Chart
Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $2.16B, an increase of 2,053.29%. That is a compound annual growth rate of 11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.13B | 29.51% |
| Dec 31, 2025 | 1.64B | 5.43% |
| Dec 31, 2024 | 1.56B | 26.96% |
| Dec 29, 2023 | 1.23B | -42.68% |
| Dec 30, 2022 | 2.14B | -14.12% |
| Dec 31, 2021 | 2.49B | 89.46% |
| Dec 31, 2020 | 1.32B | 245.25% |
| Dec 31, 2019 | 381.00M | -56.94% |
| Dec 31, 2018 | 884.80M | 83.11% |
| Dec 29, 2017 | 483.20M | 3.49% |
| Dec 30, 2016 | 466.90M | -38.31% |
| Dec 31, 2015 | 756.80M | -13.40% |
| Dec 31, 2014 | 873.90M | 94.59% |
| Dec 31, 2013 | 449.10M | 522.02% |
| Dec 31, 2012 | 72.20M | -35.36% |
| Dec 30, 2011 | 111.70M | -51.92% |
| Dec 31, 2010 | 232.30M | -7.38% |
| Dec 31, 2009 | 250.80M | 378.63% |
| Dec 31, 2008 | 52.40M | -77.65% |
| Dec 31, 2007 | 234.50M | -30.60% |
| Dec 29, 2006 | 337.90M | -23.72% |
| Dec 30, 2005 | 443.00M | 252.71% |
| Dec 31, 2004 | 125.60M | 3.37% |
| Dec 31, 2003 | 121.50M | 614.71% |
| Dec 31, 2002 | 17.00M | -75.61% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kiniksa Pharmaceuticals International, | 3.53B |
| Prestige Consumer Healthcare | 3.18B |
| Liquidia | 3.17B |
| Supernus Pharmaceuticals | 3.10B |
| HUTCHMED (China) | 2.46B |
| Bausch Health Companies | 1.99B |
| Phibro Animal Health | 1.94B |
| ANI Pharmaceuticals | 1.55B |